Journal article
Successful treatment of Epstein-Barr virus encephalitis in the setting of HIV-associated neurocognitive disorder: A diagnostic and therapeutic challenge
JM Trevillyan, AA Mahony, C McLean, JF Hoy
Antiviral Therapy | INT MEDICAL PRESS LTD | Published : 2013
DOI: 10.3851/IMP2451
Abstract
We report a challenging case of HIV-associated neurocognitive disorder with superimposed Epstein-Barr virus (EBV) encephalitis. The patient presented with an abnormal MRI brain scan, and EBV DNA that was detected in the cerebrospinal luid and brain biopsy, which also demonstrated histopathological indings consistent with the diagnosis. This occurred on the background of a 12-month period of gradual cognitive decrease secondary to HIV-associated dementia. Invasive testing was required to reach the diagnosis in this case, highlighting the importance of thorough investigation of neurological impairment in HIV-positive patients. Clinicopathological recovery was achieved through optimization of a..
View full abstractGrants
Funding Acknowledgements
JFH has served on advisory boards for Gilead Sciences, ViiV Healthcare, Janssen Cilag and Merck, Sharp & Dohme. Her institution has received research support from Merck, Sharp & Dohme and Gilead Sciences, and honoraria for speaking or chairing engagements from Gilead Sciences and Janssen Cilag. All other authors declare no competing interests.